Home › Compare › DTRK vs JNJ

DTRK vs JNJ: Dividend Comparison 2026

DTRK yields 500.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DTRK wins by $61399.50M in total portfolio value
10 years
DTRK
DTRK
● Live price
500.00%
Share price
$0.40
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$61399.52M
Annual income
$44,063,578,515.70
Full DTRK calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — DTRK vs JNJ

📍 DTRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDTRKJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DTRK + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
DTRK pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DTRK
Annual income on $10K today (after 15% tax)
$42,500.00/yr
After 10yr DRIP, annual income (after tax)
$37,454,041,738.34/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, DTRK beats the other by $37,454,041,034.73/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DTRK + JNJ for your $10,000?

DTRK: 50%JNJ: 50%
100% JNJ50/50100% DTRK
Portfolio after 10yr
$30699.77M
Annual income
$22,031,789,671.74/yr
Blended yield
71.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DTRK
No analyst data
Altman Z
-15.5
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DTRK buys
0
JNJ buys
0
No recent congressional trades found for DTRK or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDTRKJNJ
Forward yield500.00% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$61399.52M ✓$20.0K
Annual income after 10y$44,063,578,515.70 ✓$827.78
Total dividends collected$59892.67M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DTRK vs JNJ ($10,000, DRIP)

YearDTRK PortfolioDTRK Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$60,700$50,000.00$10,676$355.77+$50.0K → DTRK
2$348,594$283,644.86$11,407$389.39+$337.2K → DTRK
3$1,895,372$1,522,376.89$12,198$426.53+$1.88M → DTRK
4$9,763,990$7,735,942.00$13,056$467.62+$9.75M → DTRK
5$47,691,977$37,244,507.54$13,987$513.12+$47.68M → DTRK
6$221,049,019$170,018,603.23$14,998$563.56+$221.03M → DTRK
7$972,993,924$736,471,474.07$16,098$619.52+$972.98M → DTRK
8$4,070,762,075$3,029,658,575.98$17,295$681.69+$4070.74M → DTRK
9$16,201,818,371$11,846,102,950.68$18,599$750.82+$16201.80M → DTRK
10$61,399,524,173$44,063,578,515.70$20,022$827.78+$61399.50M → DTRK

DTRK vs JNJ: Complete Analysis 2026

DTRK — Stock

DATATRAK International, Inc., a technology and services company, provides unified clinical solutions and related services for the clinical trials industry. The company offers DATATRAK ONE Unified Experience, a clinical enterprise solution that allows clinical users and service providers to design, deliver, and manage clinical trials. Its products include UX CTMS 360 for planning and managing trials; UX Trial to streamline design-to-deployment process using a tool; UX EDC & Medical Coding for capturing and delivering data; UX Randomization and Trial Supply Management to randomize patients and automate supply; UX Patient Data Capture; UX Safety; and UX Training to train users and track certificates. The company also provides DATATRAK Clinical Consulting Services, such as training, support, learning center, Software as a Service hosting, standards, and trial design services. It serves contract research organizations, pharma and biotech companies, and clinical trial device companies. DATATRAK International, Inc. was founded in 1991 and is headquartered in Mayfield Heights, Ohio.

Full DTRK Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this DTRK vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DTRK vs SCHDDTRK vs JEPIDTRK vs ODTRK vs KODTRK vs MAINDTRK vs ABBVDTRK vs MRKDTRK vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.